Cleveland Diagnostics Names Jack Kenny as Chairman of the Board
Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, today announced the appointment of Jack Kenny as Chairman of the Board of Directors. Kenny joins the company at a pivotal time as Cleveland Diagnostics accelerates commercial growth following recent FDA approval of its IsoPSA® IVD Assay and expands its broader IsoClear™ platform.
